scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013789113 |
P356 | DOI | 10.1038/SJ.GT.3301469 |
P698 | PubMed publication ID | 11423934 |
P5875 | ResearchGate publication ID | 11916474 |
P2093 | author name string | Weibel M | |
Büeler H | |||
Paterna JC | |||
Furler S | |||
P2860 | cites work | The cleavage activities of aphthovirus and cardiovirus 2A proteins | Q73016795 |
An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy | Q73479417 | ||
Production of interleukin-12 as a self-processing 2A polypeptide | Q77357481 | ||
??? | Q64821040 | ||
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein | Q22251280 | ||
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism | Q24515072 | ||
Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system | Q28141743 | ||
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders | Q29614754 | ||
Mapping of functional domains in eukaryotic protein synthesis initiation factor 4G (eIF4G) with picornaviral proteases. Implications for cap-dependent and cap-independent translational initiation | Q29615969 | ||
Internal ribosome entry site biology and its use in expression vectors. | Q33744842 | ||
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers | Q33782809 | ||
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer | Q33802811 | ||
Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. | Q33855715 | ||
Insertional mutagenesis of AAV2 capsid and the production of recombinant virus | Q33883772 | ||
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. | Q35057135 | ||
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. | Q35111738 | ||
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector | Q35872651 | ||
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina | Q36439639 | ||
Proteolytic processing of picornaviral polyprotein | Q38004542 | ||
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. | Q39580820 | ||
Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. | Q39719268 | ||
Expression of a foreign protein by influenza A virus. | Q40038220 | ||
IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector | Q40863150 | ||
The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures | Q40992568 | ||
Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers | Q41034868 | ||
Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins | Q41044142 | ||
Co-expression of human adenosine deaminase and multidrug resistance using a bicistronic retroviral vector | Q41057898 | ||
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. | Q42609041 | ||
Tricistronic and tetracistronic retroviral vectors for gene transfer | Q42796226 | ||
Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy | Q42812515 | ||
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer | Q42824650 | ||
Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence | Q43729049 | ||
Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants | Q43817184 | ||
Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors | Q43822089 | ||
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors | Q45299117 | ||
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. | Q45745995 | ||
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters | Q45764253 | ||
Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus | Q45766162 | ||
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector | Q45855552 | ||
Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors | Q45867424 | ||
Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain | Q45869654 | ||
Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. | Q45888779 | ||
Self-processing 2A-polyproteins--a system for co-ordinate expression of multiple proteins in transgenic plants. | Q53933906 | ||
Viral gene delivery selectively restores feeding and prevents lethality of dopamine-deficient mice | Q64381642 | ||
Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors | Q67503391 | ||
P433 | issue | 11 | |
P921 | main subject | substantia nigra | Q753278 |
vector-borne disease | Q2083837 | ||
mouth disease | Q2508462 | ||
P304 | page(s) | 864-873 | |
P577 | publication date | 2001-06-01 | |
P1433 | published in | Gene Therapy | Q15763095 |
P1476 | title | Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons | |
P478 | volume | 8 |
Q39578448 | A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells |
Q40318156 | A novel bicistronic expression system composed of the intraflagellar transport protein gene ift25 and FMDV 2A sequence directs robust nuclear gene expression in Chlamydomonas reinhardtii |
Q40011728 | Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct |
Q38011650 | Challenges in T cell receptor gene therapy. |
Q34117035 | Comparison of IRES and F2A-based locus-specific multicistronic expression in stable mouse lines. |
Q40477022 | Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. |
Q34244585 | Coordinate lentiviral expression of Cre recombinase and RFP/EGFP mediated by FMDV 2A and analysis of Cre activity |
Q54125189 | Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons. |
Q36150485 | Development of 2A peptide-based strategies in the design of multicistronic vectors |
Q24683066 | Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1 |
Q42088656 | Dual transgene expression by foamy virus vectors carrying an endogenous bidirectional promoter |
Q35219552 | Dual transgene expression in murine cerebellar Purkinje neurons by viral transduction in vivo |
Q42375722 | Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells |
Q47965594 | Expression of Cholesterol Hydroxylase/Lyase System Proteins in Yeast S. cerevisiae Cells as a Self-Processing Polyprotein |
Q51735696 | Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents. |
Q39827307 | Faithful expression of multiple proteins via 2A-peptide self-processing: a versatile and reliable method for manipulating brain circuits. |
Q30537577 | Genetic dissection of an amygdala microcircuit that gates conditioned fear |
Q42448457 | Herpes simplex virus type 1/adeno-associated virus hybrid vectors |
Q45383286 | Immunogenicity and protective efficacy of Semliki forest virus replicon-based DNA vaccines encoding goatpox virus structural proteins |
Q38812436 | Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide |
Q37323354 | Live Attenuated Vaccine Based on Duck Enteritis Virus against Duck Hepatitis A Virus Types 1 and 3. |
Q41614860 | MGMT enrichment and second gene co-expression in hematopoietic progenitor cells using separate or dual-gene lentiviral vectors. |
Q42141797 | Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI |
Q34966685 | Optimisation of the foot-and-mouth disease virus 2A co-expression system for biomedical applications. |
Q44165281 | Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. |
Q35970584 | Overexpression of the Fibroblast Growth Factor Receptor 1 (FGFR1) in a Model of Spinal Cord Injury in Rats. |
Q64941735 | Oxytocin-dependent reopening of a social reward learning critical period with MDMA. |
Q38441659 | Production and characterization of soluble human TNFRI-Fc and human HO-1(HMOX1) transgenic pigs by using the F2A peptide |
Q34987192 | Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain |
Q96768562 | Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice |
Q41820621 | Protein coexpression using FMDV 2A: effect of "linker" residues. |
Q34987182 | Recombinant adeno-associated virus vector design and gene expression in the mammalian brain |
Q37305521 | Reporting neural activity with genetically encoded calcium indicators |
Q40091495 | Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins |
Q39975879 | Sustained analgesic peptide secretion and cell labeling using a novel genetic modification |
Q39996419 | Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states |
Q89548826 | The first full genome characterization of an Iranian foot and mouth disease virus |
Q30653057 | The knottin-like Blufensin family regulates genes involved in nuclear import and the secretory pathway in barley-powdery mildew interactions |
Q38841457 | The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo. |
Q38438132 | The use of an adeno-associated viral vector for efficient bicistronic expression of two genes in the central nervous system |
Q33908524 | Use of the 2A peptide for generation of multi-transgenic pigs through a single round of nuclear transfer. |
Q33369539 | Use of the viral 2A peptide for bicistronic expression in transgenic mice |
Q34285870 | Versatile somatic gene transfer for modeling neurodegenerative diseases |
Search more.